Table 3.
Group | Subgroups | Number | Chi2 | P-Value | I2 (%) |
---|---|---|---|---|---|
All | 7 | 10.92 | 0.09 | 45% | |
Treatment duration | ≥4 weeks | 2 | 0.00 | 0.97 | 0.0% |
<4 weeks | 5 | 5.17 | 0.27 | 23% | |
Sample size | ≥25 | 2 | 0.00 | 0.97 | 0.0% |
<25 | 5 | 5.17 | 0.27 | 23% | |
Geographic location | Asia | 3 | 1.60 | 0.45 | 0.0% |
Others | 4 | 2.56 | 0.46 | 0.0% | |
Study design | Parallel trial | 3 | 2.27 | 0.32 | 12% |
Crossover trial | 4 | 4.45 | 0.22 | 33% |